Literature DB >> 1777503

Why woman partners of drug users will continue to be at high risk for HIV infection.

J B Cohen1.   

Abstract

Women infected with Human Immunodeficiency Virus (HIV) via a sexual relationship with an infected drug using partner are the second largest group of women diagnosed with AIDS in this country. Since 1983, they have been the most rapidly growing subgroup of adults with AIDS, and the increase has been even more rapid among black and hispanic women. Because they are a diverse group and are not readily identified, women partners of drug users and their needs have been unknown to or neglected by service providers and programs that could help them avoid becoming infected. More complete understanding of their characteristics and needs can help in the development of sensitive educational, preventative, and therapeutic strategies to help slow the dramatically increasing burden of AIDS-related morbidity and mortality among them and their families.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Age Factors; Americas; Barrier Methods; Behavior; Biology; Blacks--women; Condom; Contraception; Contraceptive Methods; Critique; Cultural Background; Demographic Factors; Developed Countries; Diseases; Drug Usage; Economic Factors; Education; Ethnic Groups; Examinations And Diagnoses; Family Planning; Health Education; Hispanics--women; Hiv Infections--prevention and control; Hiv Infections--transmission; Hiv Serodiagnosis; Infant; Iv Drug Users--men; Laboratory Examinations And Diagnoses; Needs--women; North America; Northern America; Obstacles; Organization And Administration; Population; Population At Risk; Population Characteristics; Prostitutes--women; Research Methodology; Risk Factors; Sex Behavior; Sexual Partners--women; United States; Viral Diseases; Youth

Mesh:

Year:  1991        PMID: 1777503     DOI: 10.1300/J069v10n04_08

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  1 in total

1.  The risk of HIV infection in a national sample of women with injection drug-using partners.

Authors:  S Tortu; M Beardsley; S Deren; W R Davis
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.